Proudly serving innovative life sciences organizations around the world

We’re proud to help our 500+ customers bring their life-enhancing treatments to the public. We match our platform and service offerings to the operational and scientific needs of each customer, whether small/medium-size pharma or biotech, global health care companies, medical device manufacturers, diagnostic and biomarker developers, academic and government researchers, or CROs—large, specialty, clinical-stage and emerging.

Celltrion Logo
Worldwide Leader in Biosimilar Development and Medidata Enhance Clinical Research Programs for RA, Respiratory Diseases, Cancer, and More
“Celltrion conducts more multi-regional clinical trials than any other life sciences company in Korea, and Medidata will provide powerful and scalable technology to ensure the success of our biosimilars development programs”
– Sang-Joon Lee, VP, Celltrion
Read more
Ono Pharmaceuticals Logo
ONO Selects Medidata to Power Clinical Trials Exploring Additional Cancer Indications for Immunotherapy Drug
“At ONO, we are pushing medical and scientific frontiers with the goal of making patients’ lives better. Working with Medidata, we’ve been able to demonstrate the efficacy of OPDIVO for a select group of aggressive cancers. Now, we look forward to expanding use of the Medidata platform as we further explore the potential for immunotherapy to transform oncology care.”
– Satoru Fukimbara, Ph.D., Manager, Data Science and Clinical Development, Ono Pharmaceutical
Read more
Boehringer Ingelheim Logo
Medidata Clinical Cloud Enables Top-20 Global Pharma to Conduct Faster, More Accurate and More Cost-Effective Clinical Trials
“Boehringer Ingelheim creates therapeutic value through continuous innovation, so fortifying our R&D efforts with smart, agile technology is vital to our continued success. Medidata’s platform of cloud-based solutions and data analytics will increase the efficiency of our R&D and help us be more nimble in developing and conducting increasingly complex clinical trials."
– Klaus Stern, Head of Biostatistics & Data Sciences, Boehringer Ingelheim
Read more
C&R Research Logo
Medidata and Leading Korean CRO C&R Research Optimize Study Operations and Data Quality
"Partnering with a technology company that has deep life sciences expertise is essential to our success, and Medidata really understands our mission and R&D needs. Their platform—which includes a holistic, risk-based monitoring solution—is helping us improve operational efficiencies and decision-making processes throughout the clinical trial lifecycle."
– Moon Tae Yoon, President, C&R Research
Read more
Infinity Pharma Logo
Infinity Pharmaceuticals Uses Medidata's Risk-Based Monitoring Solution to Propel Oncology Research
“As strong proponents of risk-based monitoring, we share Medidata’s vision and are pleased to be incorporating their comprehensive RBM solution into our clinical study. Medidata continues to be a trusted and seasoned advisor, enabling us to leverage cutting-edge technology and process optimization in our clinical trial programs. We look forward to making the most of Medidata’s expertise as we take a holistic approach to risk-based monitoring.”
– Ross Pettit, SVP of Development Operations, Infinity Pharmaceuticals
Read more
Chonbuk University Logo
Korean Chonbuk University Hospital Aligns with Medidata for Enterprise EDC Solution
"It's imperative that we stay at the forefront of innovation in our industry to ensure the development of high-quality therapies for those in need. Medidata’s cutting-edge technology has been proven in trials around the world—of all sizes and for all phases and therapy areas—and we look forward to maximizing our trial efficiencies, ultimately helping to accelerate the delivery of innovative new medicines to patients."
– Tae Sun Park, Director, CUH Global Center
Read more